A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

A new study published Thursday found that groundbreaking weight loss and diabetes medications also combat opioid-use disorder and alcohol misuse disorder. This is the second study this fall to suggest ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

在全球对肥胖症治疗愈加重视的背景下，礼来的减肥神药被广泛关注。但就在最近，FDA（美国食品和药物管理局）宣布，礼来公司两款主要的GLP-1类注射剂——Zepbound和Mounjaro的供应短缺问题已经得到解决，这让很多关注减肥药物的人倍感兴奋。但对仿制药厂商Hims&Hers来说，却是一场重大的打击，其股价盘中一度大跌15%。那么，调控政策的变化究竟意味着什么？

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

Health Secretary Wes Streeting has suggested that new weight loss injections such as Ozempic or Mounjaro could be given to ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...

Here are insights into Tori Spelling’s weight loss journey and how the actress toned herself down. From medications to diet ...